Table 2 Demographics and clinical presentation of patients who had fructose or fructan hydrogen breath tests (HBTs)
Characteristics | All Patients (n = 186) | Patients Positive for Fructose HBT (n = 71) | Patients Negative for Fructose HBT (n = 115) | Patients Positive for Fructan HBT (n = 91) | Patients Negative for Fructan HBT (n = 95) | Patients Positive for Both HBTs (n = 42) | Patients Negative for Both HBTs (n = 66) |
|---|---|---|---|---|---|---|---|
Age, median years (Q1-Q3) | 36.7 (29.6–47.5) | 38.8 (29.8–51.2) | 34.8 (28.5–43.6) | 37.6 (29.8–47.2) | 34.8 (28.6–46.4) | 39.9 (29.8–52.3) | 34.0 (28.0–43.5) |
Male, n (%) | 70 (37.6) | 26 (36.6) | 43 (37.4%) | 30 (33.0%) | 41 (43.2%) | 17 (40.5%) | 29 (43.9%) |
Symptoms, n (%) | Â | Â | Â | Â | Â | Â | Â |
 Bloating | 133 (71.5%) | 47 (66.2%) | 86 (74.8%) | 68 (74.7%) | 65 (68.4%) | 27 (67.3%) | 45 (68.2%) |
 Abdominal Pain | 118 (63.4%) | 40 (56.3%) | 78 (67.8%) | 58 (63.7%) | 60 (63.2%) | 23 (54.8%) | 43 (65.2%) |
 Diarrhea | 79 (42.5%) | 30 (42.3%) | 49 (42.6%) | 39 (42.9%) | 40 (42.1%) | 19 (45.2%) | 29 (43.9%) |
 Constipation | 48 (25.8%) | 19 (26.8%) | 29 (25.2%) | 27 (29.7%) | 21 (22.1%) | 13 (31.0%) | 15 (22.7%) |
 Increased Flatulence | 28 (15.1%) | 11 (15.5%) | 17 (14.8%) | 11 (12.1%) | 17 (17.9%) | 5 (11.9%) | 11 (16.7%) |
 Nausea | 29 (15.6%) | 11 (15.5%) | 18 (15.7%) | 19 (20.9%) | 10 (10.5%) | 7 (16.7%) | 6 (9.1%) |
 Acid Reflux | 23 (12.4%) | 5 (7.0%) | 18 (15.7%) | 10 (11.0%) | 13 (13.7%) | 0 (0.00%) | 8 (12.1%) |
 Fecal Urgency | 25 (13.4%) | 9 (12.7%) | 16 (13.9%) | 14 (15.4%) | 11 (11.6%) | 7 (16.7%) | 9 (13.6%) |
 Weight Loss | 12 (6.5%) | 4 (5.6%) | 8 (7.0%) | 6 (6.6%) | 6 (6.3%) | 1 (2.4%) | 3 (4.6%) |
 Vomiting | 8 (4.3%) | 4 (5.6%) | 4 (3.5%) | 5 (5.5%) | 3 (3.2%) | 3 (7.1%) | 2 (3.0%) |
 Appetite Loss | 9 (4.8%) | 4 (5.6%) | 5 (4.4%) | 3 (3.3%) | 6 (6.3%) | 1 (2.4%) | 3 (4.6%) |
 Nonspecific Extraintestinal Complaints | 36 (19.4%) | 12 (16.9%) | 25 (20.9%) | 13 (14.3%) | 23 (24.2%) | 5 (11.9%) | 16 (24.2%) |